DE29512719U1 - Monoklonale Antikörper gegen humanes Interleukin-10 - Google Patents

Monoklonale Antikörper gegen humanes Interleukin-10

Info

Publication number
DE29512719U1
DE29512719U1 DE29512719U DE29512719U DE29512719U1 DE 29512719 U1 DE29512719 U1 DE 29512719U1 DE 29512719 U DE29512719 U DE 29512719U DE 29512719 U DE29512719 U DE 29512719U DE 29512719 U1 DE29512719 U1 DE 29512719U1
Authority
DE
Germany
Prior art keywords
monoclonal antibodies
antibodies against
against human
human interleukin
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE29512719U
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE29512719U priority Critical patent/DE29512719U1/de
Publication of DE29512719U1 publication Critical patent/DE29512719U1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
DE29512719U 1995-07-28 1995-07-28 Monoklonale Antikörper gegen humanes Interleukin-10 Expired - Lifetime DE29512719U1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE29512719U DE29512719U1 (de) 1995-07-28 1995-07-28 Monoklonale Antikörper gegen humanes Interleukin-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE29512719U DE29512719U1 (de) 1995-07-28 1995-07-28 Monoklonale Antikörper gegen humanes Interleukin-10

Publications (1)

Publication Number Publication Date
DE29512719U1 true DE29512719U1 (de) 1996-08-29

Family

ID=8011501

Family Applications (1)

Application Number Title Priority Date Filing Date
DE29512719U Expired - Lifetime DE29512719U1 (de) 1995-07-28 1995-07-28 Monoklonale Antikörper gegen humanes Interleukin-10

Country Status (1)

Country Link
DE (1) DE29512719U1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074388A1 (en) * 2000-03-31 2001-10-11 Idec Pharmaceuticals Corporation Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074388A1 (en) * 2000-03-31 2001-10-11 Idec Pharmaceuticals Corporation Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
US6896885B2 (en) 2000-03-31 2005-05-24 Biogen Idec Inc. Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma

Similar Documents

Publication Publication Date Title
DE69617896D1 (de) Humaner monoklonaler Antikörper gegen VEGF
NO980915D0 (no) Rekombinante anti-CD4-antistoff egnet for human terapi
NO955167D0 (no) Monoklonalt anti-
IL136335A0 (en) Monoclonal human natural antibodies
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
DE69637408D1 (de) Antikörper gegen cd-80
IS4662A (is) Innúðatæki
DE69634279D1 (de) Verbinder
IS4698A (is) Innúðatæki
DE69602671D1 (de) Verbinder
DK0830166T3 (da) Inhalationsapparat
EP0977590A4 (de) Menschliche monoklonale antikörper
DE69322847D1 (de) Monoklonaler Antikörper gegen menschliches Ceruloplasmin
DE69621746D1 (de) Verbinder
DE29512719U1 (de) Monoklonale Antikörper gegen humanes Interleukin-10
DE69427850D1 (de) Monoklonaler antikörper gegen mucoglykoprotein
BR9709080A (pt) Anticorpo monoclonal anti-MP52 humano
BR9609863A (pt) Fecho
DE29522009U1 (de) Portionstube
DE29503415U1 (de) Leuchter
UA10736A (uk) Ћ†љ
DE29502894U1 (de) Brillen - Haltespirale
KR970026705U (ko) 우산의 물받이
KR970007899U (ko) 파라솔
DE29520272U1 (de) Restentleerbare Tube

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 19961010

R156 Lapse of ip right after 3 years

Effective date: 19990501